This amendment permanently subjects funding for the CFPB to congressional appropriation and authorizes funding for fiscal year 2020 at the fiscal year 2019 level. The Consumer Financial Protection Bureau is currently funded by the Federal…
Michael Burgess
The Public Record
Michael Clifton Burgess is an American politician and physician who has served as the U.S. Representative for Texas's 26th congressional district since 2003. A member of the Republican Party, Burgess has focused on healthcare policy, leveraging his medical background to inform his legislative work. He has been involved in various committees and has advocated for issues such as medical research and veterans' healthcare. Burgess has also been a vocal supporter of conservative fiscal policies and has participated in discussions surrounding healthcare reform.
May I inquire as to how much time I have remaining. The Acting CHAIR. The gentleman from Texas has 3 minutes remaining.
I demand a recorded vote. The Acting CHAIR. Pursuant to clause 6 of rule XVIII, further proceedings on the amendment offered by the gentleman from Texas will be postponed. Amendment No. 8 Offered by Mr. Cohen The Acting CHAIR. It is now in…
I have an amendment at the desk. The Acting CHAIR. The Clerk will designate the amendment. The text of the amendment is as follows: Redesignate section 9 as section 10. Insert after section 8 the following: SEC. 9 BRINGING THE AGENCY INTO…
It is especially important that, as we evaluate this legislation, we consider the possibility of unintended consequences for both the patient and for the market.
I believe in private industry. I believe that, when the Government gets in things, the entry to the industry only gets more difficult.
We are getting to a place where things that were just unthinkable a few years ago are now within our grasp.
I think Secretary Azar is onto something when he says we ought to disclose what the cost to the patient would be.
We cannot ignore that. We should not randomly categorize as bad actors those who have done what this committee has, frankly, encouraged them to do, investing in cutting-edge therapies like gene editing and regenerative medicine, because…





